Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Схожие документы

• Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
  по: Chowdhury, O, и др.
  Опубликовано: (2018)
• Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
  по: Bing Li, и др.
  Опубликовано: (2017-05-01)
• Mechanisms of disease transformation in myeloproliferative neoplasms
  по: O'Sullivan, J
  Опубликовано: (2022)
• Heterogeneity in myeloproliferative neoplasms: causes and consequences
  по: O'Sullivan, J, и др.
  Опубликовано: (2018)
• Profile of pomalidomide and its potential in the treatment of myelofibrosis
  по: Gowin KL, и др.
  Опубликовано: (2015-04-01)